I-1.HKU ithe umuthi wokugomela ikhala we-COVID-19 kanye nomgomo womkhuhlane ungahlanganiswa ube munye.
umuthi wokugomela amakhala we-COVID-19 owenziwe ngokuhlanganyela yiNyuvesi yaseHong Kong, i-Xiamen University kanye ne-Beijing Wantai Biological Pharmaceutical Co., Ltd. usanda kugunyazwa yi-State Drug Administration ukuze usetshenziswe ezimweni eziphuthumayo ezwenikazi.Inyuvesi yaseHong Kong iphendule ophenyweni lwentatheli yeChina News Service ukuthi enye yezimpawu zalo mgomo wamakhala we-COVID-19 ukuthi ungahlanganiswa nomgomo womkhuhlane.
I-2.Waterloo, izinhlobonhlobo eziyizigidi eziyizinkulungwane ezingu-3, idale "umqhele wokuthengisa" omusha we-antiemetics!
Isicanucanu nokuhlanza okubangelwa i-chemotherapy kungenye yezindlela ezivame kakhulu zokusabela ezingezinhle zeziguli ezinomdlavuza.Imithi elwa nokuqunjelwa kanye ne-anti nausea ihlukaniswa njengesimiso sokugaya ukudla nemithi ye-metabolic, kodwa isetshenziswa kakhulu ekwelapheni ukuhlanza okubangelwa izidakamizwa ezilwa nesimila emisebenzini yomtholampilo, futhi idlala indima ebalulekile emkhakheni wokwelapha isimila.Ngokusho kwedatha evela ku-Minei.com, usayizi wemakethe wezidakamizwa ezilwa ne-antiemetics kanye ne-antinausea ematheminali ezikhungo zezokwelapha zomphakathi e-China engxenyeni yokuqala ka-2022 udlule ama-yuan ayizigidi eziyizinkulungwane ezingu-2.9.I-Qilu Pharmaceutical iqhubekile nokuhola imakethe.I-Zhengda Tianqing Pharmaceutical Group iphuthume ku-TOP2.Imithi emisha ye-Hengrui Class 1 isingene emtholampilo weSigaba sesi-III, futhi umjikelezo omusha wokushova umkhiqizo usuzoqala.
3.Ithrekhi ye-Double anti R&D iyashisa!I-Xinda nezinye izinkampani zithole imakethe ebiza ngaphezu kwezigidigidi ezingama-200
Muva nje, imakethe elwa nezidakamizwa ekabili ibishisa bhe: I-Kangfang Biotech kanye ne-Summit Therapeutics sebefinyelele ekutholeni amalayisense aphesheya kwezilwandle afinyelela ku-R5 bhiliyoni amadola aseMelika ngomkhiqizo ombaxambili wokulwa nezidakamizwa i-AK112, kanye no-Wuhan Youzhiyou Biotech, ucwaningo nokuthuthukiswa kwezidakamizwa zasekhaya. Enterprise, ithumele isicelo sayo sokufakwa kuhlu kwe-IPO… Iqhutshwa imakethe evumayo, isidakamizwa esilwa nobabili siyakwamukela ukuchuma kocwaningo nentuthuko.Njengamanje, kunezinhlobo ezingaba ngu-80 zamasosha omzimba aphindwe kabili esigabeni somtholampilo e-China.I-Xinda Bio, i-Shiyao Holding, i-Roche, njll. zinemikhiqizo emine noma ngaphezulu ngaphansi kocwaningo.Imikhiqizo eyishumi nantathu ye-Hengrui Pharmaceutical, efana ne-SHR-1701, i-Zanidatamab yase-Baiji Shenzhou, isesigabeni sesi-III somtholampilo.Amasosha omzimba aphindwe kabili asekelwe kokuhlosiwe kwe-CD47/PD-L1 yiwona adume kakhulu, futhi imikhiqizo emihlanu yenza ukuhlolwa komtholampilo.I-CDE yakhe uchungechunge lwezimiso eziqondisayo ezindabeni ezidinga ukunakwa okuphuthumayo ocwaningweni lomtholampilo nasekuthuthukisweni kwemithi elwa nesimila ephindwe kabili, Ukuqondisa amabhizinisi ukuze enze ucwaningo lwesayensi lomtholampilo olwengeziwe kanye nokuthuthukiswa kwama-anti-tumor akabili.
4.Ubhubhane lomkhuhlane omubi kunayo yonke kule minyaka eyishumi edlule selufikile!Isibalo sokulaliswa esibhedlela ezifundazweni zase-US senyukile
Ngokombiko omayelana nesikhathi sendawo sesi-5 se-Axios, iwebhusayithi yezindaba yase-US, umkhuhlane omubi kakhulu eminyakeni engaphezu kweshumi usuhlasele uhlelo lwezempilo nolwezempilo obelusengcupheni yokuwohloka ngenxa yobhubhane lwe-COVID-19 kanye ne-syncytial yokuphefumula. igciwane (RSV).
Kubikwa umkhuhlane lo wenze phose zonke izifundazwe zibe lezinga eliphezulu kumbe eliphezulu kakhulu lomkhuhlane lo.
Ngokusho kwe-US Centers for Disease Control and Prevention (CDC), inani lokulaliswa esibhedlela okuhlobene nomkhuhlane ngesikhathi se-Thanksgiving licishe liphindeke kabili kusukela ngesonto eledlule, eliphakeme kakhulu kusukela ngesizini yomkhuhlane ka-2010-2011.Phakathi kwabo, abantu abadala abaneminyaka engu-65 nangaphezulu kanye nezingane ezineminyaka engu-4 nangaphansi bathinteka kakhulu, ikakhulukazi uma benezinkinga zempilo ezingaba khona.
Kodwa-ke, cishe u-40% wabantu baseMelika uthe bebengahlelile ukugomela umkhuhlane kule sizini, ikakhulukazi ngoba bekhathazekile ngomthelela omubi noma imiphumela engemihle yomgomo.
Ochwepheshe bezempilo yomphakathi bathi eminyakeni emibili edlule, imaski nezinye izindlela zokuvimbela ubhubhane lwe-COVID-19 zinqande kakhulu umkhuhlane futhi zavimba ukusakazeka kwawo ngesizini.Kodwa-ke, njengoba abantu bebuyela ezimpilweni zabo zangaphambi kobhubhane, basengozini enkulu yokutheleleka.
Ngonyaka odlule, ithimba labacwaningi labikezela ukuthi uma izindlela zokuzivikela sezisusiwe, isimo esiwumqedazwe wezingane sizophindeka kakhulu.Abacwaningi banxuse ukuthi kusetshenziswe “uhlelo lokugoma lokulandela” oluqinile.
I-CDC ilinganisela ukuthi, kuze kube manje, okungenani abantu abayizigidi eziyisi-8.7 sebegula, abangama-78000 balaliswe esibhedlela kanti abangama-4500 bashonile ngesikhathi somkhuhlane.
Ngokusho kwe-CNN, uhulumeni waseBiden uthembise ukuhlinzeka ngezinsizakusebenza kanye nabasebenzi ukusiza uhlelo lwezempilo lwasendaweni ukubhekana nokuqubuka komkhuhlane, kodwa ngeke akucabange ukumemezela isimo esiphuthumayo sezempilo yomphakathi.
Ngokusho kwedatha ye-CDC, phakathi kuka-2009 no-2022, izinga lokulaliswa komkhuhlane wabantu abadala base-Afrika baseMelika cishe liphakeme ngo-80% kunelabantu abadala abamhlophe.Kodwa-ke, ngesizini yomkhuhlane ka-2021-2022, bangaphansi kwama-43% abantu abadala base-Afrika baseMelika, abaseSpanishi kanye naboMdabu baseMelika abagonyiwe.
Encwadini ayibhalele izifundazwe, uNobhala woMnyango Wezempilo Nezinsizakalo Zabantu e-US, uXavier Bessela, ubhale ukuthi uhulumeni wobumbano angangenelela ukusiza uhlelo lwezokwelapha olubhekene nengcindezi, njengokuvumela izibhedlela ezishodayo ukuthi zijabulele ukukhululwa ukuze zikhuphuke. amandla okwelapha iziguli, noma azenze zibe mathubeni amaningi okudlulisa iziguli ezinomkhuhlane, i-COVID-19 noma i-RSV.
I-JinDun Medicalinokubambisana kocwaningo lwesayensi yesikhathi eside kanye nokuxhunyelelwa kwezobuchwepheshe namanyuvesi aseShayina.Ngezinsiza zezokwelapha ezicebile ze-Jiangsu, inobudlelwano besikhathi eside bokuhwebelana ne-India, i-Southeast Asia, iNingizimu Korea, iJapan nezinye izimakethe.Iphinde inikeze izinsizakalo zemakethe nezokuthengisa kuyo yonke inqubo kusukela ku-API yomkhiqizo omaphakathi kuya oqediwe.Sebenzisa izinsiza eziqoqiwe ze-Yangshi Chemical kukhemistri ye-fluorine ukuze unikeze izinsizakalo ezikhethekile zokwenza amakhemikhali ngokwezifiso kozakwethu.Nikeza inqubo emisha kanye nezinsizakalo zocwaningo lokungcola ukuze uqondise amakhasimende.
I-JinDun Medical iphikelela ekudaleni iqembu elinamaphupho, lenze imikhiqizo enesithunzi, ecophelelayo, eqinile, futhi iphume konke ukuze ibe uzakwethu othembekile kanye nomngane wamakhasimende! professionalukukhiqizwa kwemithi ngokwezifiso(i-CMO) kanye nabahlinzeki besevisi be-R&D bezemithi kanye nokukhiqiza (CDMO).UJindun uzokuphelezela ukuyochitha i-COVID-19.
Isikhathi sokuthumela: Dec-16-2022